06/02/2025 4:28 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form DEF 14A | |
06/02/2025 4:29 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form DEFA14A | |
06/02/2025 4:30 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form ARS | |
05/27/2025 8:19 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B5 | |
05/27/2025 8:20 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2025 4:08 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form PRER14A | |
05/15/2025 8:33 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2025 4:26 PM | bioAffinity Technologies (Subject) bioAffinity Technologies, Inc. (Subject) Crumly Richard K. (Filed by)
| Form SCHEDULE 13G | |
05/08/2025 4:12 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2025 8:27 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B4 | |
05/05/2025 11:15 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for BIAF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter.
|
05/05/2025 8:31 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form S-1/A | |
05/02/2025 5:42 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
04/29/2025 4:29 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 10-K/A | |
04/20/2025 11:15 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form EFFECT | |
04/15/2025 4:03 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form PRE 14A | |
04/14/2025 3:05 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2025 4:22 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
03/31/2025 4:10 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/31/2025 8:30 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2025 7:49 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2025 8:29 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/25/2025 4:30 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B5 | |
02/25/2025 4:30 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B5 | |
02/07/2025 4:20 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/14/2025 3:15 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Zannes Timothy P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:15 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Edwards James Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:15 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Zannes Maria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:15 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/14/2025 3:15 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) GIRGENTI STEVEN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2025 3:15 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Reveles Xavier Trinidad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/23/2024 3:15 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/09/2024 4:05 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B3 | |
12/08/2024 11:15 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form EFFECT | |
11/27/2024 4:17 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
11/22/2024 4:24 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B3 | |
11/22/2024 4:24 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B3 | |
11/22/2024 4:25 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B3 | |
11/22/2024 3:27 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form DEF 14A | |
11/14/2024 3:34 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024 8:28 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
5 Stocks Poised to Soar Under Trump's Presidency (Ad) With the next presidential cycle heating up and Trump leading the charge, major market shifts are already taking shape.
For investors who position early, the opportunities could be significant.
That’s why we’ve just released a brand-new report:
📈 “5 Best Stocks to Buy Under Trump’s Presidency.” Get the full report here—and stay ahead of the curve. |
11/13/2024 8:19 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form PRE 14A | |
11/05/2024 6:05 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Edwards James Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 12:54 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/21/2024 8:29 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B5 | |
10/21/2024 8:30 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2024 8:23 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 8:16 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 7:00 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 4:01 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Edwards James Michael (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/19/2024 11:15 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form EFFECT | |
09/11/2024 4:30 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
09/05/2024 3:30 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form DEF 14A | |
08/23/2024 4:15 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/23/2024 4:17 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form PRE 14A | |
08/14/2024 8:37 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024 8:00 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B5 | |
08/05/2024 8:03 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/02/2024 8:30 AM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 424B5 | |
07/09/2024 3:30 PM | bioAffinity Technologies (Filer) bioAffinity Technologies, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 5:47 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) KNIGHT PETER S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:47 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Harvey Sandler Revocable Trust (Reporting) Rubin Gary D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:47 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Zannes Maria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:47 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Platt Jamie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:47 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Joyce Roby (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:47 PM | Anderson Robert A. (Reporting) bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:47 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) GIRGENTI STEVEN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:47 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) DIAMOND STUART (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 8:27 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Harvey Sandler Revocable Trust (Reporting) Rubin Gary D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 7:45 PM | Anderson Robert A. (Reporting) bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 7:45 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) KNIGHT PETER S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 7:45 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Platt Jamie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 7:45 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Joyce Roby (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 7:45 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) Zannes Maria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 7:46 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) GIRGENTI STEVEN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 7:46 PM | bioAffinity Technologies (Issuer) bioAffinity Technologies, Inc. (Issuer) DIAMOND STUART (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |